Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...

Citi analyst Geoff Meacham lowered the firm’s price target on Eli Lilly to $1,190 from $1,250 and keeps a Buy rating on the shares. Ahead of ...

Study urges industry to be more transparent and fairer in selecting speakers, and to recruit more women to steering ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...

Eli Lilly & Co. on Tuesday will ask the Seventh Circuit to set a standard process for determining when workers can pool ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...